Observations on the Cuticle Ultrastructure of Meloidogyne hapla Males

Por Johnson, P. W.
Publicado em 1981

Survival from non-Hodgkin lymphoma in England and Wales up to 2001

Por Johnson, P W M
Publicado em 2008

In situ morphology of nitrifying-like bacteria in aquaculture systems.

Por Johnson, P W, Sieburth, J M
Publicado em 1976

The treatment of multiple myeloma--an important MRC trial.

Por Johnson, P. W., Selby, P. J.
Publicado em 1994

Rituximab: mechanisms and applications

Por Johnson, P W M, Glennie, M J
Publicado em 2001

Reaction of a nucleoside 2, 4-dinitrophenyl phosphate with fluoride; a convenient method for the preparation of the nucleoside phosphorfluoridate.

Por Johnson, P W, von Tigerstrom, R, Smith, M
Publicado em 1975

The molecular detection of circulating tumour cells.

Por Johnson, P. W., Burchill, S. A., Selby, P. J.
Publicado em 1995

Detection, enumeration, and sizing of planktonic bacteria by image-analyzed epifluorescence microscopy.

Por Sieracki, M E, Johnson, P W, Sieburth, J M
Publicado em 1985

Cuticle Ultrastructure of Hemicycliophora arenaria, Aphelenchus avenae, Hirschmanniella gracilis and Hirschmanniella belli

Por Johnson, P. W., Van Gundy, S. D., Thomson, W. W.
Publicado em 1970

Cuticle Formation in Hemicycliophora arenaria, Aphelenchus avenae and HirschmannIella gracilis

Por Johnson, P. W., Van Gundy, S. D., Thomson, W. W.
Publicado em 1970

The use of erythropoietin in a Jehovah's Witness undergoing major surgery and chemotherapy.

Por Johnson, P. W., King, R., Slevin, M. L., White, H.
Publicado em 1991

Ex-vivo assays of dendritic cell activation and cytokine profiles as predictors of in vivo effects in an anti-human CD40 monoclonal antibody ChiLob 7/4 Phase I trial

Por Chowdhury, F., Johnson, P. W., Glennie, M.J., Williams, A. P.
Publicado em 2013

Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureter.

Por Papamichael, D., Gallagher, C. J., Oliver, R. T., Johnson, P. W., Waxman, J.
Publicado em 1997

Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential?

Por Nolan, L, Johnson, P W M, Ganesan, A, Packham, G, Crabb, S J
Publicado em 2008

Double modulation of 5-fluorouracil with interferon alpha 2a and high-dose leucovorin: a phase I and II study.

Por Seymour, M. T., Johnson, P. W., Hall, M. R., Wrigley, P. F., Slevin, M. L.
Publicado em 1994

Neurological illness following treatment with fludarabine.

Por Johnson, P. W., Fearnley, J., Domizio, P., Goldin, J., Nagendran, K., Gawler, J., Rohatiner, A. Z., Lister, T. A.
Publicado em 1994

Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas.

Por Johnson, P. W., Whelan, J., Longhurst, S., Stepniewska, K., Matthews, J., Amess, J., Norton, A., Rohatiner, A. Z., Lister, T. A.
Publicado em 1993

Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer.

Por Johnson, P. W., Joel, S. P., Love, S., Butcher, M., Pandian, M. R., Squires, L., Wrigley, P. F., Slevin, M. L.
Publicado em 1993

A less toxic regimen of 5-fluorouracil and high-dose folinic acid for advanced gastrointestinal adenocarcinomas.

Por Johnson, P. W., Thompson, P. I., Seymour, M. T., Deasy, N. P., Thuraisingham, R. C., Slevin, M. L., Wrigley, P. F.
Publicado em 1991

Phase II trial of temozolomide in low-grade non-Hodgkin's lymphoma.

Por Woll, P. J., Crowther, D., Johnson, P. W., Soukop, M., Harper, P. G., Harris, M., Brampton, M. H., Newlands, E. S.
Publicado em 1995